Has Jeb Justice, MD received payments from drug or device companies?

Yes. Drug and device makers reported $142,428 in general payments to Jeb Justice, MD across 155 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeb Justice, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeb Justice, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeb Justice, MD

Otolaryngology · Gainesville, FLNPI 1689842429

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $101,292 of the $142,428 with a category attached, or 71.1%. 12 manufacturers reported payments, led by Intersect ENT, Inc. at 51.7% of the total. Reporting peaked in 2019 at $47,754 and has fallen 74.5% since, to $12,181 in 2025. Among otolaryngology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$142,428in general payments, 2019–2025

Across 155 payments — averaging $918.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intersect ENT, Inc.$74K
Medtronic$51K
Sanofi$9K
Regeneron Healthcare Solutions, Inc.$5K
3-d Matrix, Inc.$3K
AbbVie$84
plus $276 from 6 others

$169,748in research payments, 2019–2025

Across 145 payments — averaging $1170.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Regeneron$85K
GSK$44K
AstraZeneca$41K

What the payments were for

Consulting fees$21,64415%
Speaking & faculty fees$101,29271%
Grants$3400%
Travel & lodging$14,50810%
Food & beverage$4,6443%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intersect ENT, Inc.	61	$73,651
Medtronic(2 entities)	62	$50,644
Sanofi	7	$9,408
Regeneron Healthcare Solutions, Inc.	7	$5,211
3-d Matrix, Inc.	2	$3,154
AbbVie	1	$84
GSK	4	$79
Acclarent, Inc	4	$62
Optinose US, Inc.	3	$48
Boston Scientific	2	$39
Stryker	1	$30
AstraZeneca	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

PROPEL$26,475
SINUVA$18,196
DUPIXENT$5,421
STRAIGHTSHOT$2,030

How this compares

$142,428 in reported general payments places this provider in the 95th percentile of 586 otolaryngology providers in Florida.

See all otolaryngology providers in Florida →

Medicare billing

Part B allowed, 2024

$253,900

Medicare patients

363

Services billed

1,324

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent SyringeDupilumab	58	$255,221
Tranexamic Acid	22	$4,827
Ipratropium Bromide	53	$1,966
Doxycycline Hyclate	52	$1,446
Mupirocin	46	$873
Sodium ChlorideSodium Chloride Irrig Solution	17	$770
Fluticasone Propionate	45	$602
Azelastine Hcl	17	$461
Cefdinir	12	$410
Clindamycin Hcl	16	$333
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	20	$280
Ciprofloxacin Hcl	24	$234
Montelukast Sodium	13	$145
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	11	$127
Prednisone	39	$123

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Gainesville

John WestineGainesville$86K
Brian LoboGainesville$30K
Si ChenGainesville$25K
Peter DziegielewskiGainesville$10K
Cecelia DamaskOrlando$707K
Ralph TufanoSarasota$469K
Franklin RimellFort Myers$314K
David BrodnerBoynton Beach$209K
Maria SuurnaMiami$189K
Jane DillonOrmond Beach$180K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →